Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA
Clinical trial NCT05667662 · TERMINATED
Trial details
- NCT number
- NCT05667662
- Sponsor
- Pulmatrix Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-02-27
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.